MYC and familial pancreatic carcinoma: To further determine the synergetic role of c-Myc inhibitors and dFdC in pancreatic cancer, dFdC at 16.7 and 2.8 nM (concentration that causing 85% survival rate of Panc-1 and Mia-Paca cells, respectively) was selected for subsequent combinational experiment.